(Q36404994)

14 August 2017

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination (English)

1 reference

14 August 2017

United States of America

1 reference

inferred from title

cervix uterine cancer

1 reference

inferred from title

author

Jeremy Goldhaber-Fiebert

series ordinal

1

object named as

Jeremy D Goldhaber-Fiebert

0 references

Sue Goldie

series ordinal

5

object named as

Sue J Goldie

1 reference

14 August 2017

6

Joshua A Salomon

1 reference

14 August 2017

4

Karen M Kuntz

1 reference

14 August 2017

Natasha K Stout

2

1 reference

14 August 2017

Jesse Ortendahl

series ordinal

3

1 reference

14 August 2017

language of work or name

1 reference

29 October 2007

1 reference

Population Health Metrics

14 August 2017

1 reference

14 August 2017

5

1 reference

14 August 2017

11

1 reference

Creative Commons Attribution 2.0 Generic

14 August 2017

start time

29 October 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Model for assessing human papillomavirus vaccination strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence of HPV infection among females in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysm.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Novel metaheuristic for parameter estimation in nonlinear dynamic biological systems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Chapter 7: Achievements and limitations of cervical cytology screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Chapter 13: Current findings from prophylactic HPV vaccine trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Chapter 2: The burden of HPV-related cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Bayesian methods for evidence synthesis in cost-effectiveness analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Evidence synthesis, parameter correlation and probabilistic sensitivity analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Effect of screening and adjuvant therapy on mortality from breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

The epidemiological impact of antiretroviral use predicted by mathematical models: a review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Evaluating human papillomavirus vaccination programs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence of human papillomavirus genotypes in women from three clinical settings

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Estimating age conditional probability of developing disease from surveillance data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

The frequency of Pap smear screening in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Gaussian process modeling in conjunction with individual patient simulation modeling: a case study describing the calculation of cost-effectiveness ratios for the treatment of established osteoporosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Age-conditional probabilities of developing cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Cost-effectiveness of a potential vaccine for human papillomavirus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Empirically calibrated model of hepatitis C virus infection in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Evaluation of cervical cytology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Concordance of human papillomavirus in the cervix and urine among inner city adolescents

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Comparison of human papillomavirus genotypes in archival cervical cancer specimens from Alaska natives, Greenland natives and Danish Caucasians

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Incidence of cervical squamous intraepithelial lesions in HIV-infected women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Detection of genital human papillomavirus and associated cytological abnormalities among college women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Increased prevalence of abnormal Papanicolaou smears in urban adolescents

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Genital HPV infections in children and adolescents.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Natural history of cervical intraepithelial neoplasia: a critical review.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Results of data analysis of mass Papanicolaou screening of 796,337 women in the United States in 1981.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Model building on the basis of Dutch cervical cancer screening data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Determinants of genital human papillomavirus infection in young women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Biotinyl-tyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence of infection with carcinogenic human papillomavirus among older women

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Human papillomavirus infection in women infected with the human immunodeficiency virus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prevalence and incidence rates of cervical atypia. A computerized file analysis of 148,735 patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Racial differences in the risk of invasive squamous-cell cervical cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Prognostic significance of polymerase chain reaction detected human papillomavirus of tumors and lymph nodes in surgically treated stage IB cervical cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Cervical cancer incidence in a prevaccine era in the United States, 1998-2002.

28 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975–2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness of cervical-cancer screening in five developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Benefits and costs of using HPV testing to screen for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Natural history of cervicovaginal papillomavirus infection in young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Natural history of cervical squamous intraepithelial lesions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Diagnoses and outcomes in cervical cancer screening: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Mutations of p53 and human papillomavirus infection in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Approximate Is Better than "Exact" for Interval Estimation of Binomial Proportions

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Increasing the efficiency of Monte Carlo cohort simulations with variance reduction techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

The theoretical population-level impact of a prophylactic human papilloma virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Model uncertainty--parameter uncertainty versus conceptual models.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

The natural history of type-specific human papillomavirus infections in female university students.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

A longitudinal analysis of human papillomavirus 16 infection, nutritional status, and cervical dysplasia progression

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Epidemiology of Acquisition and Clearance of Cervical Human Papillomavirus Infection in Women from a High‐Risk Area for Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1478-7954-5-11

Multiparameter Calibration of a Natural History Model of Cervical Cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2213637

The prevalence of HR-HPV DNA in ASC-US Pap smears: A military population study

5 December 2018

1 reference

12 December 2020

Determinants of genital human papillomavirus detection in a US population

1 reference

12 December 2020

Prevalence and persistence of human papillomavirus in postmenopausal age women

1 reference

12 December 2020

Human papillomavirus and prognosis of invasive cervical cancer: a population-based study

1 reference

12 December 2020

Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis

1 reference

12 December 2020

Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population

1 reference

12 December 2020

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

12 December 2020

Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results

1 reference

12 December 2020

Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction

1 reference

12 December 2020

Distribution of human papillomavirus types in cervicovaginal washings from women evaluated in a sexually transmitted diseases clinic

1 reference

12 December 2020

Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001

1 reference

12 December 2020

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

12 December 2020

Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions

1 reference

12 December 2020

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

1 reference

12 December 2020

Cervical cancer screening among low-income women: results of a national screening program, 1991-1995

1 reference

12 December 2020

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

1 reference

12 December 2020

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

12 December 2020

Pap test results among low-income youth: prevalence of dysplasia and practice implications

1 reference

12 December 2020

The Wisconsin Breast Cancer Epidemiology Simulation Model

1 reference

12 December 2020

Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study

1 reference

12 December 2020

Dysplasia and carcinoma in situ of the uterine cervix: prevalence in very young women (under age 22). A one-year study in a health plan population

1 reference

12 December 2020

Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities

1 reference

12 December 2020

High risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy

1 reference

12 December 2020

Monte Carlo probabilistic sensitivity analysis for patient level simulation models: efficient estimation of mean and variance using ANOVA

1 reference

12 December 2020

Identifiers

DOI

10.1186/1478-7954-5-11

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

17967185

1 reference